We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Direct Molecular Assay Developed for Zika Diagnosis

By LabMedica International staff writers
Posted on 14 Aug 2019
Print article
Image: The Mini8 Plus real time polymerase chain reaction (RT-PCR) thermocycler (Photo courtesy of Coyote Bioscience).
Image: The Mini8 Plus real time polymerase chain reaction (RT-PCR) thermocycler (Photo courtesy of Coyote Bioscience).
Zika virus (ZIKV), a mosquito-borne Flavivirus, is a positive single-stranded RNA virus with a nucleic acid length of about 10.7kb. This virus has been spreading rapidly and there have been large-scale outbreaks worldwide in recent years. ZIKV has drawn attention as it may cause severe symptoms while no specific medical treatment or vaccine is currently available.

The direct reverse-transcription quantitative polymerase chain reaction (dirRT-qPCR) amplification method simplifies the operating process, reduces the time from sample-to-answer detection, reduces the risk of exposure to infectious substances, and reduces the sample volume required from the milliliter level to as low as the sub-microliter level.

Laboratory medical scientists working with their associates at the Guangdong Medical University (Dongguan, PR China) collected nine clinical samples of ZIKV infection that included three saliva, two serum, one throat swab, two urine, and one whole blood specimens. All normal clinical specimens, 54 dengue virus (DENV)-positive samples, and eight chikungunya virus (CHIKV)-positive samples were also obtained.

The team optimized a combination of inhibitor-tolerant polymerases, polymerase enhancers, and dirRT-qPCR conditions were optimized for various clinical samples including blood and serum. Sensitivity was evaluated with standard DNA spiked in simulated samples. Specificity was evaluated using clinical specimens of other infections such as DENV and CHIKV virus. The dirRT-qPCR reactions were performed in a quantitative 7500 PCR instrument with a volume of 25 μL. The dirRT-qPCR reactions for detecting ZIKV infection in the clinical samples were performed in a Mini8 Plus RT-PCR thermocycler.

Clinical validation of the specificity of the established dirRT-qPCR assay was performed using a total of 83 clinical samples (nine ZIKV-positive samples, four CHIKV-positive whole blood samples and four CHIKV-positive serum samples, 27 DENV-positive serum samples (15 DENV-1, nine DENV-2, one DENV-3, and two DENV-4), 27 DENV-positive whole blood samples (15 DENV-1, nine DENV-2, one DENV-3, and two DENV-4), and 12 normal samples. Five µL of each sample was added directly to the dirRT-qPCR assay. All experiments included a negative control (NTC). High specificity and sensitivity were achieved, and the limit of detection (LOD) of the assay was 9.5 × 101 ZIKV RNA copies/reaction. The on-site clinical diagnosis of ZIKV required a 5μL sample and the diagnosis could be completed within two hours.

The authors concluded that their robust dirRT-qPCR assay shows a high potential for point-of-care diagnosis, and the primer–probe combinations can also be extended for other viral detection. It realizes the goal of large-scale on-site screening for viral infections and could be used for early diagnosis and the prevention and control of viral outbreaks. The study was published in the August 2019 edition of the International Journal of Infectious Diseases.

Related Links:
Guangdong Medical University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.